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Abstract
Recent advances in the field of intravital imaging have for the first time allowed us to conduct pharmacokinetic and
pharmacodynamic studies at the single cell level in live animal models. Due to these advances, there is now a critical need
for automated analysis of pharmacokinetic data. To address this, we began by surveying common thresholding methods to
determine which would be most appropriate for identifying fluorescently labeled drugs in intravital imaging. We then
developed a segmentation algorithm that allows semi-automated analysis of pharmacokinetic data at the single cell level.
Ultimately, we were able to show that drug concentrations can indeed be extracted from serial intravital imaging in an
automated fashion. We believe that the application of this algorithm will be of value to the analysis of intravital microscopy
imaging particularly when imaging drug action at the single cell level.
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Introduction
Since the advent of intravital imaging, it has been possible to
perform single cell and population analysis of tumor biology in vivo.
In recent years, these methods have also been adapted to the study
of drug pharmacology [1,2], which has been in part enabled by
commercially available compounds as well as a growing number of
fluorescently labeled therapeutic companion drugs [3–6]. To fully
realize the potential of this imaging approach, however, and to
maximize the data that can be mined in a reasonable time frame,
it will be necessary to overcome several challenges. Specifically,
intravital imaging videos typically display (i) dense cell fields made
up of multiple layers of cells; (ii) cells presenting heterogeneous
fluorescent intensity due to differences in the Z location of the cells
and to stochastic biological processes; and (iii) movement artifacts
due to cellular movement in three dimensions (3-D) as well as to
displacement of the anesthetized animal being imaged [7,8]. Due
to these unique features, segmentation of intravital imaging data is
challenging, requiring advanced image processing techniques.
A number of different image segmentation methods have been
reported. Examples commonly used in cell-based applications
include edge detection, watershed-based methods, as well as
others. Perhaps the most widely used method for cell segmentation
is the relatively simple process of thresholding, where an algorithm
is used to separate foreground and background pixels based on the
differences between the two classes. This paper therefore focuses
on thresholding methods due to their simplicity, their implemen-
tation, and their already widespread use amongst biologists.
Within thresholding methods, a number of approaches have
already been described [9], including: (i) histogram shape-based
methods which function by analyzing histogram peaks and curves;
(ii) clustering based methods that divide pixels into two groups,
foreground and background, via analysis of global intensity values,
to create a segmented image (iii) entropy based methods which
utilize the entropic properties of the image foreground and
background to segment the image, (iv) object attribute methods
that look for commonalities among certain object features for
image segmentation; (v) spatial methods that binarize images
based on advanced correlations/statistical methods focusing on
properties of pixels; and (vi) locally adaptive methods which utilize
local information to threshold images in subgroups of local
neighborhoods. For segmenting cells and thresholding microscopic
images, each of these strategies have advantages depending on the
data quality and data type required [7]. Otsu’s method [10] is
perhaps one of the most common thresholding techniques, and
represents an example of a clustering method that functions by
thresholding the gray levels of an image into two distinct segments
via minimization of variance in each respective group. This
technique works most effectively on images where the fluorescent
target of interest is relatively uniform in brightness and where the
background is similar across the whole of the image; unfortunately,
this is not always the case during time lapse imaging of
intravenously administered fluorescent drugs. Huang’s method
[11] is an example of an object attribute method, where in this
case, the attribute of interest is the object ‘‘fuzziness’’ measure.
Ray’s method [12] is an example of an iterative, locally adaptive
thresholding method with only three inputs: the number of
iterations for determining the threshold, the ‘‘power’’ (a single
adjustment that determines the selectivity of the thresholding
sequence), and a termination condition setting denoted as
‘‘epsilon’’. The primary drawbacks of this method are (i) due to
its iterative nature, it is computationally intensive; and (ii) unlike
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degree of user input.
The overall goal of the present study was thus to (i) determine a
suitable thresholding method for broad use in segmentation
algorithms used for intravital microscopy; (ii) utilize a standard
thresholding method to create a robust, semi-automated segmen-
tation and data mining algorithm for analyzing pharmacokinetic
data at the single cell level in in vivo images; and (iii) verify the
function of this algorithm. To validate the method, we chose to use
videos of a fluorescently labeled poly ADP ribose polymerase
(PARP) inhibitor. PARP inhibitors are currently under investiga-
tion for use on tumors with BRCA deficiencies, where pharma-
cokinetics is a key issue [13–15]. Ultimately, the ability to collect
semi-automated data from in vivo images would be of considerable
benefit to the pharmacokinetic analysis of fluorescently labeled
drugs. Semi-automatic data acquisition would not only provide a
non-biased means of assessing drug distribution in cells but would
permit the acquisition of larger data sets than otherwise possible
through manual delineation of cell borders.
Materials and Methods
Tumor model
The human fibrosarcoma cell line HT-1080 was purchased
from ATCC (Manassas, VA). Cells were grown in Dulbecco’s
Modified Eagle Medium (DMEM) supplemented with 10% fetal
bovine serum (FBS) and 1% penicillin-streptomycin.
Reporter cell lines
Histone 2B-red fluorescent protein (H2B-apple) was used to
identify the nuclei of individual cancer cells since this model has
previously been shown to be robust in vivo [2]. pmApple-N1
(Myo1E-pmApple-C1, Addgene, Prof. Christien Merrifield [16])
was cloned by ligating Apple into pmCherry-N1 (Clontech) using
AfeI and BsrG1 restriction enzymes. The pTag-H2B-Apple
construct was generated by subcloning mApple from pmApple-
N1 into pTag-H2B-BFP (Evrogen) using AgeI and NotI. Correct
insertion of Apple was confirmed by sequencing the insert in its
entirety.
pTag-H2B-Apple was transfected into HT1080 cells using the
X-tremeGENE HP transfection reagent (Roche), and followed by
selection in 500 mg/ml G418. Single clones were screened for
H2B-Apple expression by fluorescence microscopy. Multiple
clones showing high fluorescence were selected by fluorescence
activated cell sorting, and the brightest 5% of cells were then
isolated for expansion. Cells were maintained in Minimum
Essential Medium (MEM) supplemented with 10% FBS, 100
I.U. penicillin, 100 mg/ml streptomycin, 2 mM L-glutamine, non-
essential amino acids and 100 mg/ml G418.
Intravital microscopic imaging
All animal experiments were carried out in accordance with
guidelines from the Institutional Subcommittee on Research
Animal Care. Nude mice (Cox7, Massachusetts General Hospital)
were surgically implanted with a dorsal skin window chamber.
Approximately 3–4610
6 cells, suspended in 1:1 phosphate buffered
saline (PBS) and Matrigel (BD Biosciences, Franklin Lakes, NJ),
were implanted under the fascia and allowed to grow for ,2 weeks.
As soon as the tumors became vascularized and had reached 1–
2 mm in size, mice were anesthetized with 2% isoflurane in 2 L/
minute oxygen on a heated microscope stage. They were then
injected via tail vein catheter with either Angiosense-680 (Perkin
Elmer, Waltham, MA) or 250 mg of a 500 kDa amino-dextran
labeled with Pacific Blue N-Hydroxysuccinimide (NHS) ester
(Invitrogen, Grand Island, NY), according to the manufacturer’s
instructions. Vascularized regions of interest in the tumor were
identified by the vessel probe and by the H2B-Apple tumor signal;
regions with minimal out-of-plane vessels were chosen for imaging.
Time-lapse imaging was initiated prior to injection of the drug. The
drug was formulated by dissolving 7.5 mL of a 1 mM solution in
dimethyl sulfoxide (DMSO) together with 30 mL of a 1:1
dimethylacetamide (DMAc):solutol solution. 112.5 ml PBS was then
slowly added with sonication to obtain a final injection volume of
150 mL.
Static and time series images were collected using a customized
Olympus FV1000 based on a BX61-WI confocal microscope
(Olympus America). A XLUMPLFLN 206 water immersion
objective (NA 1.0, Olympus America) was used for data collection.
BODIPY-FL, H2B-Apple, and vascular probes were scanned and
excited sequentially using a 405 nm, a 473-nm, a 559-nm and/or
a 633 nm diode laser, respectively, in combination with a DM405
488/559/635-nm dichroic beam splitter. Emitted light was then
separated and collected using appropriate combinations of beam
splitters (SDM473, SDM560, and/or SDM 640) and emission
filters BA430–455, BA490–540, BA575–620, BA575–675, and/or
BA655–755 (all Olympus America). Control tumors were used to
determine good settings for voltage and laser power, and to
optimize imaging conditions by ensuring that no photobleaching
or phototoxicity occurred with the imaging settings used. Time-
lapse movies were corrected for small shifts using the StackReg
plugin in ImageJ (vers. 1.47a). Typically, images were acquired
every 75 seconds for the duration of experiments.
Thresholding Survey and Algorithm Implementation
A survey of thresholding images was initially conducted either
using the freely available image processing software ImageJ
(National Institutes of Health, Bethesda, MA) or by implementa-
tion into Matlab (Mathworks, Natick, MA). Promising methods
were then implemented into an image-processing algorithm in
Matlab. Quantitative comparisons were created manually using
the freeware GNU Image Manipulation Program (GIMP, Groton,
MA) by two independent reviewers (Supplemental Fig. 1).
Comparisons were applied to both manual images and the results
are presented as averages.
Fluorescent Drug
A solution of boron-dipyrromethene-fluorine (BODIPY-FL)
succinimidyl ester (5.0 mg, 12.8 mmol; Invitrogen, Carlsbad, CA)
in acetonitrile (250 mL) was reacted with a solution of 4.7 mg
(12.8 mmol, dissolved in 250 mL acetonitrile) of 4-[[4-fluoro-3-
(piperazine-1-carbonyl)phenyl]methyl]-2H-phthalazin-1-one [17]
in the presence of triethylamine (4.6 mL, 64.2 mmol). The two
components reacted together cleanly within 4 hours at room
temperature. The product AZD2281-BODIPY FL was then
isolated using standard high-performance liquid chromatography
(HPLC) techniques performed on a Waters (Milford, MA) liquid
chromatography–mass spectrometry (LC-MS) system and using a
Waters XTerraH C18 5 mm column. The title compound was
isolated in 72% yield and its identity confirmed using LC/MS,
HPLC, nuclear magnetic resonance (NMR) and high resolution
mass spectrometry (HRMS) techniques. The compound had a
maximum absorbance at 507 nm and a maximum emission at
527 nm. This compound has previously been shown to retain
similar bioactivity to the unmodified drug [18].
Statistical Analysis
For data analysis, values for each of three individual measure-
ment methods were compiled and ranked following evaluation of
Intravital Pharmacokinetic Analysis
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analysis see Supplemental Fig. 2). After ranking, an analysis using
Friedman’s rank sums test was used to evaluate whether any
statistical differences were present among the distributions. For
sets where a difference was detected, the Wilcoxon rank sum test
was used as a pairwise test to determine group subset differences.
The p values,0.05 were considered significant.
Results
Thresholding Method Comparison and Selection
We initially surveyed a variety of thresholding algorithms using
sample pharmacokinetic data (Table 1). Promising methods,
including a clustering based method (Otsu), an object attribute
method (Huang), and a locally adaptive method (Ray), were then
further analyzed against a range of intravital image data sets.
Representative images displaying four different imaging compli-
cations (uneven fluorescence expression, a high cell density field,
a high cell density field with uneven fluorescence expression, and
high magnification images with interior details) were selected.
These were subsequently used to quantitatively compare the
different thresholding methods. Images obtained using a manual
threshold were compared mathematically to individual thresh-
olding methods (see below). Visual comparisons are shown in
Figure 1. The overall goal of these quantitative measures was to
determine the suitability of each method for pharmacokinetic
analysis in intravital imaging. Calculations were thus focused on
the amount of correctly classified area as well as on the
correctness of the number of regions. These measures seem to
be the most appropriate for data acquisition of this type, since
they focus on sources of error in intravital pharmacokinetic
analysis, such as incorrectly classified background or foreground
pixels, the presence of large numbers of artifacts following
thresholding, and/or bias against fluorescence intensity hetero-
geneity.
Misclassification error (ME) [19] reflects the percentage of
background pixels wrongly characterized as foreground, as well as
the percentage of foreground pixels wrongly characterized as
background. If Bo and BT are the background pixels of the initial
and thresholded images respectively, and if Fo and FT are the
foreground pixels respectively, and if |… | represents the
cardinality of the set, ME is described as,
ME~1{
Bo\BT jj z Fo\FT jj
Bo jj z Fo jj
We subsequently calculated a simple measurement of total
region number nonuniformity (TRNU) by assuming that Ro is
equal to the total number of regions found in the manually
thresholded image, and that RT is the number of regions found in
the images following each of the other thresholding methods,
TRNU~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Ro{RT ðÞ
2
q
Ro
Finally, we were interested in comparing the range of
fluorescent intensities in the manually thresholded image to the
range of intensities present in each image obtained via the other
thresholding methods. To do so, we modified a variance
nonuniformity measure (VNU), which typically assumes that well
segmented images will have a uniform fluorescent intensity value
[20,21]. This assumption, however, is unlikely to hold true for
intravital images containing multiple levels of fluorescent intensity.
Figure 1. A diverse set of typical intravital images was
analyzed using different thresholding methods to determine
their suitability for cell segmentation across a variety of
conditions. Cell nuclei are shown at various magnifications labeled
with H2B-Apple. I. An image displaying multiple fluorescent brightness
levels. II. A dense cell field image. III. A dense cell field with multiple
fluorescent brightness levels. IV. A high magnification image with
intracellular details. The techniques analyzed were: manual threshold-
ing, Otsu’s method, Huang’s method, and Ray’s method.
doi:10.1371/journal.pone.0060988.g001
Table 1. Image Thresholding Methods Surveyed.
Method Type Examples
Histogram Doyle [31]
Glasbey [32]
Tsai [33]
Zack [34]
Clustering Kittler [35]
Otsu [10]*
Ridler [36]
Entropy Kapur [37]
Li [38]
Shanbhag [39]
Yen [40]
Object Attribute Huang [11]*
Prewitt [41]
Spatial Beghadi [42]
Locally Adaptive Ray [12]*
A variety of methods were sampled to identify the most promising techniques
for intravital imaging analyses. Those marked with an asterisk (*) were used for
further analysis.
doi:10.1371/journal.pone.0060988.t001
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VNU~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
FT jj sT{ FM jj sM ðÞ
2
q
FM jj sM
assuming sT is the variance of the pixels in the thresholded image,
sM is the variance of the manually thresholded image and FM
represents the foreground pixels of the manually thresholded
image.
The results of our quantitative comparison between images are
presented in Figure 2. Analysis of image I showed that for most
measures, Ray’s method was superior, or equal, to Huang’s
method; Otsu’s method, however, produced unsatisfactory results
for images with multiple levels of brightness. For image II, which
consisted of a single level of brightness within a dense cell field, the
performance of all thresholding methods was approximately equal.
For image III, which consisted of a dense cell field with unequal
brightness, the results were similar to image I, whereas the Ray
and Huang methods performed at approximately the same level,
with Ray’s method perhaps performing slightly better. Finally, in
image IV, the high magnification image, Ray’s method appeared
to produce the best results, particularly for identifying outer
cellular/nuclear boundaries.
Algorithm Development
To develop a segmentation method (Fig. 3), we began by
devising an algorithm that would: (1) create a segmented image
with limited user input in an iterative and robust manner; (2)
provide secondary filtering of images (including elimination of
common defects in thresholded images e.g. image speckling); and
(3) segment/label object borders in each image (namely recognize
objects, label their borders and log their centroids in preparation
for downstream individual object tracking, if desired). By having
such features, our goal was to produce an easy-to-use algorithm,
capable of analyzing drug concentrations in a relatively hetero-
geneous range of intravital image types.
The final algorithm is a simple two-step method, which utilizes
Ray’s method, although other methods such as Otsu or Huang,
could easily be incorporated into this structure. To optimize the
thresholding and filtering procedure, the user is first asked to
define a limited set of variables: frame number to be analyzed,
gamma value of the image adjustment, the minimum object size to
be considered for analysis, the disk size used for speckling filtering,
the number of iterations to run Ray’s method, and the power
factor to run Ray’s method. Once the program applies the desired
thresholding function and variables, the results are displayed for
subsequent review by the user. The user is then given the option of
repeating the analysis or, if the initial results are acceptable,
filtering the entire video and obtaining drug properties.
Filtering thresholded images is achieved by using a combination
of two filters: a ‘‘rough pass’’ filter (a simple erosion/dilation
method that results in the removal of speckling) and a user-defined
high-pass filter that eliminates objects too small to be cells. By
using two filters, determining the optimal object size to filter in the
second portion of the program is thus simplified, since the initial
speckling filter eliminates the noisiest elements in the original
thresholded image. Image segmentation by first thresholding, and
then attenuating the results using a series of simple filters provided
excellent program flexibility as well as ease of use.
Overall object segmentation was completed using established
image processing functions [22] (see Supplemental Fig. 3 for
detailed morphological operations). Briefly, image channels
displaying cell locations and drug fluorescence were first separated.
In the cell location channel, objects were labeled using standard
Figure 2. Quantitative comparison of thresholding methods for intravital microscopy. The various thresholding methods described (Otsu,
Huang and Ray) were quantitatively compared to determine the best non-biased method(s) for each imaging type. Two independent reviewers
created manual images via cell border identification for each image (I–IV in Figure 1). Images obtained with each thresholding method were then
compared to the manually thresholded images, and averaged using various measures found in the literature including: A. the misclassification error,
which penalizes misclassified foreground and background pixels in each image; B. total region number nonuniformity, which penalizes images based
on incorrect numbers of total regions found; C. region variance nonuniformity, which compares the variance of the segmented region fluorescent
intensity between manually thresholded images and the images obtained via the other thresholding methods (Otsu, Huang and Ray); D. The average
rank order across six typical intravital images (see Supplemental Fig. 2 for additional images) for each measure (ME, misclassification error; TRNU,
region number nonuniformity; VNU, region variance nonuniformity). * p,0.05 relative to Otsu’s method, and { p,0.05 relative to Huang’s method.
doi:10.1371/journal.pone.0060988.g002
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for each object in each frame of the video. Drug concentrations
were then determined from the drug fluorescence channel by
averaging the amount of fluorescence contained within the
previously identified object borders.
Fluorescent intensities were converted into drug concentrations
via a calibration curve. Specifically, concentrations of the
BODIPY-FL labeled drug were diluted in PBS ranging from the
nanomolar to micromolar range. Images of the PBS-drug solution
were then acquired from each drug concentration utilizing the
exact microscope specifications used for animal imaging. In
addition, blood vessel concentrations of drug were also correlated
with control dilutions created in blood, verifying the calibration.
Optimal microscope settings, including laser intensity, were
determined via trial experiments in order to minimize possible
imaging and signal quantification defects. In general, these settings
precluded typical issues such as background saturation of the drug
signal or high rates of photobleaching that would significantly alter
drug concentration measurements in vivo.
Results of using the Ray Thresholding Method in 3-D
Models
In addition to thresholding individual images, a critical
component of tracking objects is to have consistency in results
over the course of a data set (i.e., the thresholding method should
produce robust results despite various imaging defects occurring
throughout a video). Thus, based on its superior performance in
our quantitative assessment as well as on its greater flexibility, we
chose to analyze results from the previously described algorithm
further using 3-D images. By using 3-D images, we were not only
able to evaluate the possibility of applying this method to 3-D
image analysis but could also determine the consistency of this
thresholding method over the course of a time lapse. Figure 4
displays the results of this analysis across a 40 mm intravital
imaging Z-stack.
Drug Concentration and Localization Tracking
We next used time-lapse videos of fluorescently labeled PARP
inhibitor to automatically extract pharmacokinetic information
from intravital images (Fig. 5A). Drug concentrations were logged
as the average of each cell’s drug concentration, and the standard
deviation of the cells; drug concentration in an area of a local
vessel is also displayed (Fig. 5B). These analyses also provide rapid
answers to broader questions such as what is the fraction of cells
with no or subtherapeutic drug concentrations at a given time
point, or how much drug is located in the nucleus versus the
cytoplasm. Using PARPi as a model, we show that at 2 hours,
during the maximum range of drug distribution and intensity, only
,3% of cells had subtherapeutic levels (defined as a 1.5 mM
concentration [23]) (Fig. 5C). In addition, by making an
assumption about the approximate size of the cytosol surrounding
the nucleus (a simple dilation of the nucleus size) in individual cells
and extrapolating this value across all cells, it was estimated that
,95% of the drug was located in the nuclear compartment at
steady state. With the addition of markers of cell membrane and
other intracellular organelles, it will be possible to generate more
detailed information regarding the behavior of the cytosolic
portion of drug distribution over time.
Figure 3. Overview of the image processing method. The left side of the diagram displays the overall proposed algorithm for analyzing
intravital images and determining drug concentration. This algorithm is made up of an iterative section that allows the user to generate the best
possible segmentation (top) and a processing module that filters through all videos after satisfactory values have been obtained. On the right, the
specific segmentation algorithm used in conjunction with the thresholding method is displayed.
doi:10.1371/journal.pone.0060988.g003
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labeled nuclei (top row) and segmented regions identified from a negative of the original image using the described segmentation algorithm
(bottom row; green outlines depict the segmented cell regions detected by the algorithm in each Z-slice). All scale bars represent 50 mm. B.
Orthogonal views of the 3D Z-stack displaying segmented cell region outlines (green) in each view. C. Summation of the Z-stack containing all
combined segmented region outlines (green).
doi:10.1371/journal.pone.0060988.g004
Figure 5. Analysis of average nuclear drug concentrations over time. A. Representative images from a 5 hour PARP inhibitor
pharmacokinetics assay. Far-Left Panel: drug distribution. Scale bar represents 50 mm. Middle-Left Panel: H2B Nuclear Marked tumor cells. Scale bar
represents 50 mm. Middle-Right Panel: merged images displaying both the drug (green) and tumor cells (red). An area of the closest vessel was also
selected to analyze the dynamics of drug distribution through the vasculature (Red box). Scale bar represents 50 mm. Far-Right Panel: Magnified cells
from the presented image shown over time. The white arrow indicates a single cell visually tracked throughout the course of the video. Scale bar
represents 10 mm. B. The average and standard deviation of nuclear drug concentration in all cells over time was analyzed using the described
segmentation algorithm. The vessel concentration dynamics were also analyzed by quantifying drug channel fluorescence within an area of the
vessel. C. The number of cells receiving a therapeutic dose of the drug over time.
doi:10.1371/journal.pone.0060988.g005
Intravital Pharmacokinetic Analysis
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Tumor and host cells are often quite mobile and can move over
considerable distances during a several hour imaging session. In
addition, despite the best efforts of most current methods of image
registration [24], some degree of animal movement may also occur
during the course of intravital imaging sessions. This makes the
acquisition of consistent data from the same subset of cells
challenging. One solution to ensuring the continuity of data is to
utilize robust tracking software to log the centroids of cells. The
process of tracking cells is normally divided into two steps: (i)
Identification of the cell to be tracked in each frame of a video and
the logging of their respective centroids (commonly referred to as
particle detection) and (ii) Linking these identified cell centroids
into coherent cell tracks (commonly referred to as particle linking
or tracking). While the detection algorithm presented here can be
easily adapted to a variety of freely available linking/tracking
algorithms, we formatted our data in this study to be used with the
tracking program created by Jaqaman [25]. This program
provides several relevant features. First, the software provides a
tracking solution for data sets with extremely challenging
conditions, such as those with dense cell fields as seen in the
images presented in this paper. Second, this program compensates
for detection failure, making it an optimal solution for an intravital
application where cells may appear or disappear. In addition,
although cell division in the time frame of videos presented in this
paper are typically not regarded as a problem (due to its relative
infrequency) [2], this software allows for merging and splitting
events to occur between particles if desired. As described,
combining our above-described algorithm with a tracking method
has the additional advantage of enabling drug concentration in
individual cells to be analyzed over time. This could potentially
yield important information regarding chemotherapeutics, where
drug resistance in the context of single cells is an area of interest.
The results from algorithm cell tracking are presented (Fig. 6A),
including 10 manually tracked cell trajectories (Fig. 6B), and 10
sample cells’ drug concentrations in a PARP mouse model
(Fig. 6C). A search radius maximum of 10 pixels was used for the
presented analysis.
Discussion
Automating microscopic image analysis of time-series (both 2D
and 3D) is currently a significant bottleneck in the analysis of in vivo
drug distribution and function at the population, single cell and
intracellular level. In a bid to alleviate this problem, an increasing
number of companion imaging drugs are being developed to study
how drugs behave and/or fail. By using these drugs in conjunction
with orthotopic models [1,26], advanced motion stabilization
techniques [27] and modeling approaches [28], it is anticipated
that valuable information regarding the pharmacokinetics and
dynamics of drugs will be revealed. Here, we developed and tested
an integrated algorithm for automating image analysis with the
ultimate output being single cell, intracellular pharmacokinetic
data.
To date, a number of thresholding methods have been
described. Otsu’s method [10] is perhaps one of the most
commonly used thresholding methods and is an example of a
clustering method that functions by thresholding the gray levels of
an image into two distinct segments. By minimizing the weighted
sum of the intraclass variances of the foreground and background
pixels, an optimal threshold level can be attained. This is because
minimizing the intra-class variance is equivalent to maximizing the
inter-class variance, which naturally yields the highest contrast
between two groups of pixels. In general, Otsu’s method works
well in situations where images have relatively equal background
and foreground pixel numbers i.e., situations where there is a
bimodal global distribution of pixel intensities/for bimodal image
histograms [29]. Unfortunately, this is not always the case with
time-lapse images. Huang’s method [11] is an example of an
attribute method based on image ‘‘fuzziness’’ levels [30], which are
defined as the difference between a gray-scale image and its binary
equivalent. This fuzziness measure is used to create a membership
function for each pixel in an image. The final threshold of the
image is then determined by minimizing the index of fuzziness, as
defined by the foreground and background pixel distributions.
Object attribute methods generally show improved performance
on images where a global threshold proves to be unsatisfactory due
to their selection of object features, rather than global intensity
levels, in the image. Ray’s method [12] is an example of a locally
adaptive thresholding method. Locally adaptive methods typically
provide superior results to methods proposing global thresholds. In
microscopy, locally adaptive methods are ideally suited for use on
images with uneven illumination since they depend on local image
characteristics rather than on a single global value for determining
a threshold. A drawback of these methods, however, is that
threshold determination is dependent on a multitude of user inputs
(for example, the thresholding window size). This means that the
quality of the threshold is dependent upon the results of a trial and
error strategy with a wide range of threshold qualities. Conse-
quently, this type of thresholding method can be time-consuming
and cumbersome. Ray’s method, however, attempts to overcome
this problem by proposing a method that iteratively calculates the
optimal weighting parameters, which in turn simplifies the
thresholding procedure. The main limitation of Ray’s method is
its current computational expense: the iterative process used to
determine the optimal thresholding parameters typically requires
Figure 6. Single Cell Pharmacokinetic Tracking. The segmenta-
tion algorithm was combined with a linking program to determine
individual cell nuclear drug concentrations. A. The locations of cell
nuclei were tracked over 5 hours, using external linking software in a
video where both cell movement and image drift were present. Red
boxes indicate arbitrarily selected cells used for manual tracking
verification of the algorithm. B. Manual tracking of arbitrarily selected
cells. C. By combining results using the segmentation algorithm
together with the tracking data, drug concentration over time in 10
sample cells could be plotted.
doi:10.1371/journal.pone.0060988.g006
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a result, there was a substantial lag time in obtaining thresholded
images compared to the other methods assessed in the present
study.
In view of its inherent advantages (Fig. 1, 2), we incorporated
Ray’s thresholding method into our workflow algorithm. To the
best of our knowledge, this is the first time that this specific
algorithm has been tested and used for cell specific segmentation
applications. As demonstrated in this work, the algorithm provides
excellent results when dealing with dense cell fields, a scenario
where most traditional thresholding methods have the greatest
problems. Specifically, the use of a local adaptive method in
segmenting cells is helpful in dealing with dense or overlapping cell
areas due to its ‘‘local’’ thresholding approach, since cells of
interest in such areas typically exhibit multiple levels of fluorescent
intensity. In effect, local adaptive methods provide the capability
for segmenting multiple levels of cells typical in intravital images,
that often appear as a single layer with heterogeneous fluorescence
intensity. In these images, overlapping cells will typically be
differentiated due to the cells contrast with each other within the
small frame of the local thresholded area (Supplemental Fig. 4). Of
course, overlapping cells with homogenous fluorescence will
require additional processing methods not utilized in this work in
order to distinguish individual borders. Overall, this algorithm
provides a framework for the analysis of single cell behavior in
intravital imaging applications, an emerging area of biological
research with currently only very limited methods available. This
framework also provides a method of cell segmentation that
could be widely adapted to other applications outside of
intravital microscopy where data analysis has traditionally
proven difficult.
Going forward, the method presented in this report could be
expanded in several ways. Firstly, while the segmentation method
provided is valid for planar segmentation, accurate 3D fluores-
cence and drug distribution analysis can only be properly
obtained by considering several additional parameters such as
high-background components due to tissue scattering, resolving
power and confocality of the imaging system, optical aberrations,
and detector noise. This is particularly true for imaging
modalities such as wide-field and laser scanning microscopy,
but is less important for confocal and multiphoton microscopy.
Additional work focusing on 3D-assisted segmentation, in
combination with image denoising and deconvolution methods,
will be the subject of further studies. Secondly, by incorporating
information regarding expected cell sizes (or sizes of other
parameters representative of intravital images), in the form of
filtering mechanisms prior to the thresholding step, the perfor-
mance of this algorithm could significantly improve. This would
also dramatically reduce the number of iterations necessary (using
Ray’s method) for the production of satisfactory results. Thirdly,
adding alternative application routines to this framework (e.g.
organelle-specific analysis, assuming an alternative intracellular
organelle fluorescence is present) would not only increase the
value of this program but would provide additional tools for
analysis. Finally, it is likely that by increasing the computational
speed of this programming framework, and by incorporating it
with on-site microscopy systems, real-time acquisition and
analysis of pharmacokinetic (or other application-specific) data
could be achieved. Ultimately, this would provide another
valuable tool for intravital microscopists.
Supporting Information
Figure S1 Comparison of manually thresholded imag-
es. To generate manual thresholding standards for Figure 1, two
independent reviewers established manual thresholds by demar-
cating (to the best of their ability) cell borders in each image.
Results from the quantitative assessment of the different thresh-
olding methods described were compared with each of the
reviewers’ images and the results were averaged.
(TIFF)
Figure S2 Additional typical intravital images used to
perform ranking analysis in Figure 2D. Images were
analyzed as described for those in Figure 1.
(TIFF)
Figure S3 Detailed view of overall morphological oper-
ations and object labeling on an example image. This
image was thresholded using Ray’s method as described, followed
by standard morphological operations to remove artifacts
produced by the thresholding process. A rainbow color labeled
image is presented to show distinct objects recognized by the
analysis program.
(TIFF)
Figure S4 (I–III) Detailed views of cells with heteroge-
neous fluorescence (indicated by arrows) and segmen-
tation of these areas via the reported algorithm.
(TIFF)
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